Meet our Speakers

Prof Philip Chiu, Chinese University of Hong Kong

Philip Chiu is currently Professor and Chief of Division of Upper GI and Metabolic Surgery, Department of Surgery; Director of Multi-Scale Medical Robotics Center; Director of Endoscopy Center, Institute of Digestive Disease; Director of CUHK Chow Yuk Ho Technology Center for Innovative Medicine and Associate Dean (External Affairs), Faculty of Medicine, Chinese University of Hong Kong (CUHK). He is also the President of Endoscopic and Laparoscopic Surgeons of Asia (ELSA).

Professor Chiu graduated from Faculty of Medicine, Chinese University of Hong Kong in 1994 with two scholarships. He became a fellow of the Royal College of Surgeons of Edinburgh, Hong Kong Academy of Medicine in 2001 and received his Doctor of Medicine from CUHK in 2009. Prof. Chiu is first to perform endoscopic submucosal dissection (ESD) for treatment of early GI cancers in Hong Kong in 2004. In 2010, he performed first Per-oral Endoscopic Myotomy (POEM) in Hong Kong as well as pioneering world first robotic gastric ESD in 2011, followed by world first robotic colorectal ESD in 2020. His research interests include esophageal cancer management, minimally invasive and robotic esophagectomy, novel endoscopic technologies for diagnosis of early GI cancers, endoscopic surgery as well as robotics for endoluminal surgery.

Currently a co-editor of Endoscopy, he has published more than 370 peer reviewed manuscripts and 6 book chapters. He has received numerous prestigious awards including State Scientific Technology and Progress Award from People’s Republic of China in 2007, 2nd class award in Technological Advancement, Ministry of Education of the People’s Republic of China in 2011. His research on POEM was awarded best of DDW 2011 and first prize of ASGE world cup of endoscopy 2012. He was selected as Asia Pacific Digestive Week JGHF Emerging Leader Lectureship in 2016 and Global Outstanding Chinese Youth 2016. He received the Gold Medal with Congratulations from Jury, 47th International Exhibitions of Inventions of Geneva in 2019 and Spirit of Hong Kong Award on Innovation in 2020.

Prof Gibson Kibiki, Kilimanjaro Clinical Research Institute

Professor Kibiki is CEO of the Africa Research Excellence Fund, a professor of medicine and consultant physician and endoscopist, who was previously the Founding CEO of the East African Health Research Commission of the East African Community, and the Founding Director of the Kilimanjaro Clinical Research Institute.

For over twenty-five years he has served as an academician, clinician, research scientist, and leader in the health sector, holding academic positions in Africa, North America, and Europe.

He has technical and managerial expertise through many years of working in the medical field in Africa and collaborating with institutions from the global North and has been key in the establishment of various regional and international research and research capacity development programmes.

Prof Yeng Ang, Salford Royal University Hospital

Prof Yeng Ang is a Consultant Gastroenterologist in Salford Royal University Hospital, Manchester, UK and an Honorary Professor, University of Manchester. He has clinical expertise in the management of GORD, Barret’s oesophagus and upper GI cancer. The main focus of his endoscopy practice is on Barret’s surveillance with imaging, HALO RFA therapy, EMR and ESD.

He has initiated a programme of translational/experimental oncology and Gastroenterology (as the lead for oesophageal Cancer Research Group in the University of Manchester). He has focused his scientific interests on the topics related to disorders including cancer and pre-neoplastic conditions such as Barrett’s oesophagus and endoscopy.  He is a supervisor for PhD and MD students in the Barrett’s Oesophagus research group and molecular cancer group of the University of Manchester.

With his expertise in interventional endoscopy and molecular cancer research, he has established a series of platforms for clinical evaluation of diagnostics/therapeutics for early cancer prevention and endotherapy, trained postgraduate students in molecular cancer, participated in and lead several UK/national and International Barrett’s Oesophagus projects (ASPECT, BOSS, ChoPIN, BobCAT, UK and Ireland RFA user group). He serves as a committee member of the BSG Oesophageal Committee, Clinical Research Group in Endoscopy and Research Committee. He is a member of the BSG/National Clinical Research Institute Upper GI early cancer prevention research subgroup.